Alberta Investment Management Corp Viatris Inc Transaction History

Alberta Investment Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $6.44 Million - $7.35 Million	-714,126 Reduced 97.75%	16,448 $164,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $1.14 Million - $1.51 Million	-130,615 Reduced 15.17%	730,574 $8.13 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $6.55 Million - $8.08 Million	658,689 Added 325.28%	861,189 $9.02 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $960,625 - $1.1 Million	72,500 Added 55.77%	202,500 $2.74 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $1.69 Million - $2.1 Million	130,000 New	130,000 $1.86 Million
Q1 2021 May 07, 2021	SELL	$13.59 - $18.54 $833,325 - $1.14 Million	-61,319 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $876,861 - $1.15 Million	61,319 New	61,319 $1.15 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.